Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes

Type 1 diabetes (T1D) is characterized by specific destruction of pancreatic insulin-producing beta cells accompanied by evidence of beta-cell-directed autoimmunity such as autoreactive T cells and islet autoantibodies (IAAs). Currently, T1D cannot be prevented or reversed in humans. T1D is easy to...

Descripción completa

Detalles Bibliográficos
Autores principales: Itoh, Arata, Ridgway, William M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448691/
https://www.ncbi.nlm.nih.gov/pubmed/28580341
http://dx.doi.org/10.2147/ITT.S117264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448691/
https://www.ncbi.nlm.nih.gov/pubmed/28580341
http://dx.doi.org/10.2147/ITT.S117264

Ejemplares similares